Sampling error, flawed analysis, and miscalculation trigger Molecular Cell retraction

molecular cell 14Guest post by Jean Hazel Mendoza

A group of researchers from France has retracted a 2013 paper from Molecular Cell after realizing that their analyses of microscopy images were flawed.

Here’s the notice for “RecA-Promoted, RecFOR-Independent Progressive Disassembly of Replisomes Stalled by Helicase Inactivation:” Continue reading Sampling error, flawed analysis, and miscalculation trigger Molecular Cell retraction

“Gremlins” caused errors in climate change paper showing gains from global warming

jep_coverThe author of a controversial 2009 paper arguing that at least some amount of global warming could lead to economic gains has corrected the paper, along with a later article in a different journal. We confess to be baffled by the implications of the mix-up, although others appear to be less confused.

The 2009 article, “The Economic Effects of Climate Change,” was written by Richard Tol, of the University of Sussex, and appeared in the Journal of Economic Perspectives. It has been cited 91 times, according to Thomson Scientific’s Web of Science.

Here’s the abstract:

Continue reading “Gremlins” caused errors in climate change paper showing gains from global warming

Nothing to see here: Unreplicable eye paper ends in retraction

jneuroimmunoThe authors of a 2012 paper in the Journal of Neuroimmunology have retracted the paper after some of the researchers were unable to verify the findings in follow-up work.

The article, “Association of transforming growth factor beta-1 (TGFB1) regulatory region polymorphisms with myasthenia gravis-related ophthalmoparesis,” came from a lab at Groote Schuur Hospital and the University of Cape Town, in South Africa.

According to the abstract: Continue reading Nothing to see here: Unreplicable eye paper ends in retraction

Seventh retraction appears for author who tampered with investigation

bioorganicsKarel Bezouška, who tried tampering with an investigation into his work by breaking into a lab refrigerator, has had a seventh paper retracted.

Here’s the notice for “Carboxylated calixarenes bind strongly to CD69 and protect CD69+ killer cells from suicidal cell death induced by tumor cell surface ligands,” which was first published in Bioorganic & Medicinal Chemistry in 2010: Continue reading Seventh retraction appears for author who tampered with investigation

Paper claiming a way to “print any drug instantly” gets unprinted

ddtA recent paper proposing a way to “print any drug instantly” has been withdrawn by the author, following bewildered reactions from the blogosphere.

The paper made the rounds at various chemistry-focused blogs last month. Derek Lowe of In The Pipeline picked up on it too, calling the article

one of the oddest papers to appear in Drug Discovery Today, which is saying something.

Apparently, the author — or someone claiming to be the author, using the initials YC — wasn’t crazy about the criticism. He left this comment on In The Pipeline and elsewhere: Continue reading Paper claiming a way to “print any drug instantly” gets unprinted

Shigeaki Kato up to 25 retractions

Shigeaki Kato
Shigeaki Kato

Shigeaki Kato, who resigned from the University of Tokyo in 2012 after being found to have inappropriately manipulated dozens of images, has two more retractions, both in Molecular Cell.

Here’s the notice for 2002’s “Nuclear Receptor Function Requires a TFTC-Type Histone Acetyl Transferase Complex:” Continue reading Shigeaki Kato up to 25 retractions

Did article on doped indium contain a doped image?

asscoverApplied Surface Science has retracted a 2010 paper by a group of researchers from India and Brazil because one of the figures in the article was suspect.

The paper was titled “Effect of hydrogenation vs. re-heating on intrinsic magnetization of Co doped In2O3.”

Continue reading Did article on doped indium contain a doped image?

Crystal unclear? “Business decision” forces retraction of silicon paper

jcgrowthA group of researchers in Tokyo has lost their 2013 article in the Journal of Crystal Growth over commercial interests — which don’t appear to be their own.

We’ll explain.

The article, “Interactions between planar defects in bulk 3C-SiC,” came from a team consisting of a researcher at Keio University and scientists at two companies, HOYA Corporation, an optics firm, and SICOXS Corporation, which makes semiconductor wafers.

According to the abstract: Continue reading Crystal unclear? “Business decision” forces retraction of silicon paper

Integrity of data “undisputed” in paper pulled for plagiarism

ijpharI shot the sheriff
But I didn’t shoot no deputy, oh no! Oh!
I shot the sheriff
But I didn’t shoot no deputy, ooh, ooh, oo-ooh.

—Bob Marley

A group of pharmacologists in Japan has retracted their 2012 article in the International Journal of Pharmaceutics for plagiarism. But not, they note, for any other reason.

The article, “Suppression of efflux transporters in the intestines of endotoxin-treated rats,” came from researchers in the Department of Drug Absorption and Pharmacokinetics in the School of Pharmacy at Tokyo University of Pharmacy and Life Sciences. It has been cited once, according to Thomson Scientific’s Web of Knowledge.

Continue reading Integrity of data “undisputed” in paper pulled for plagiarism

Anonymous blog comment suggests lack of confidentiality in peer review — and plays role in a new paper

neuronA new paper in Intelligence is offering some, well, intel into the peer review process at one prestigious neuroscience journal.

The new paper is about another paper, a December 2012 study, “Fractionating Human Intelligence,” published in Neuron by Adam Hampshire and colleagues in December 2012. The Neuron study has been cited 16 times, according to Thomson Scientific’s Web of Knowledge.

Richard Haier and colleagues write in Intelligence that Continue reading Anonymous blog comment suggests lack of confidentiality in peer review — and plays role in a new paper